New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
infectiousdiseaseadvisor.com9d
COVID-19 Vaccine: ACIP Recommends Added Doses in All With IC and Adults 65+
The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.
STAT9d
RFK Jr. and the case of the onesies: Concerns about vaccine views flare at confirmation hearing
At a Senate confirmation hearing for RFK Jr. on Wednesday, there was discussion of abortion, Medicaid, and Covid-19. There ...